131 related articles for article (PubMed ID: 27257141)
1. Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue.
Cederbye CN; Palshof JA; Hansen TP; Duun-Henriksen AK; Linnemann D; Stenvang J; Nielsen DL; Brünner N; Viuff BM
Sci Rep; 2016 Jun; 6():26997. PubMed ID: 27257141
[TBL] [Abstract][Full Text] [Related]
2. Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material.
Diestra JE; Scheffer GL; Català I; Maliepaard M; Schellens JH; Scheper RJ; Germà-Lluch JR; Izquierdo MA
J Pathol; 2002 Oct; 198(2):213-9. PubMed ID: 12237881
[TBL] [Abstract][Full Text] [Related]
3. Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival.
Wang X; Xia B; Liang Y; Peng L; Wang Z; Zhuo J; Wang W; Jiang B
Cancer Biomark; 2013; 13(2):81-8. PubMed ID: 23838136
[TBL] [Abstract][Full Text] [Related]
4. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
5. Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues.
Fetsch PA; Abati A; Litman T; Morisaki K; Honjo Y; Mittal K; Bates SE
Cancer Lett; 2006 Apr; 235(1):84-92. PubMed ID: 15990223
[TBL] [Abstract][Full Text] [Related]
6. Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence.
Lin PC; Lin HH; Lin JK; Lin CC; Yang SH; Li AF; Chen WS; Chang SC
Int J Biol Markers; 2013 Jun; 28(2):182-6. PubMed ID: 23558935
[TBL] [Abstract][Full Text] [Related]
7. Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review.
Nielsen DL; Palshof JA; Brünner N; Stenvang J; Viuff BM
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880238
[TBL] [Abstract][Full Text] [Related]
8. Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
Nie S; Huang Y; Shi M; Qian X; Li H; Peng C; Kong B; Zou X; Shen S
Oncol Rep; 2018 Oct; 40(4):2137-2146. PubMed ID: 30066914
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
[TBL] [Abstract][Full Text] [Related]
10. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.
Moran E; Larkin A; Doherty G; Kelehan P; Kennedy S; Clynes M
J Clin Pathol; 1997 Jun; 50(6):465-71. PubMed ID: 9378810
[TBL] [Abstract][Full Text] [Related]
11. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.
Candeil L; Gourdier I; Peyron D; Vezzio N; Copois V; Bibeau F; Orsetti B; Scheffer GL; Ychou M; Khan QA; Pommier Y; Pau B; Martineau P; Del Rio M
Int J Cancer; 2004 May; 109(6):848-54. PubMed ID: 15027118
[TBL] [Abstract][Full Text] [Related]
12. Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines.
Galetti M; Petronini PG; Fumarola C; Cretella D; La Monica S; Bonelli M; Cavazzoni A; Saccani F; Caffarra C; Andreoli R; Mutti A; Tiseo M; Ardizzoni A; Alfieri RR
PLoS One; 2015; 10(11):e0141795. PubMed ID: 26536031
[TBL] [Abstract][Full Text] [Related]
13. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.
Moon HH; Kim SH; Ku JL
Oncol Rep; 2016 Jan; 35(1):298-306. PubMed ID: 26497773
[TBL] [Abstract][Full Text] [Related]
15. New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues.
Tóth K; Vaughan MM; Slocum HK; Arredondo MA; Takita H; Baker RM; Rustum YM
Am J Pathol; 1994 Feb; 144(2):227-36. PubMed ID: 7508682
[TBL] [Abstract][Full Text] [Related]
16. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
17. ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma.
Wang H; Luo F; Zhu Z; Xu Z; Huang X; Ma R; He H; Zhu Y; Shao K; Zhao J
BMC Cancer; 2017 Mar; 17(1):222. PubMed ID: 28347288
[TBL] [Abstract][Full Text] [Related]
18. In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity.
Ágoston EI; Micsik T; Ács B; Fekete K; Hahn O; Baranyai Z; Dede K; Bodoky G; Bursics A; Kulka J; Krenács T; Győrffy B; Harsányi L; Szász AM
Diagn Pathol; 2016 Jul; 11(1):61. PubMed ID: 27392434
[TBL] [Abstract][Full Text] [Related]
19. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.
Anreddy N; Patel A; Zhang YK; Wang YJ; Shukla S; Kathawala RJ; Kumar P; Gupta P; Ambudkar SV; Wurpel JN; Chen ZS; Guo H
Oncotarget; 2015 Nov; 6(36):39276-91. PubMed ID: 26515463
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
